CN105112559B - A kind of kit and its application for being used to detect coronavirus - Google Patents
A kind of kit and its application for being used to detect coronavirus Download PDFInfo
- Publication number
- CN105112559B CN105112559B CN201510479272.9A CN201510479272A CN105112559B CN 105112559 B CN105112559 B CN 105112559B CN 201510479272 A CN201510479272 A CN 201510479272A CN 105112559 B CN105112559 B CN 105112559B
- Authority
- CN
- China
- Prior art keywords
- sequence
- probe
- primer pair
- coronavirus
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000711573 Coronaviridae Species 0.000 title claims abstract description 48
- 239000000523 sample Substances 0.000 claims description 73
- 230000003321 amplification Effects 0.000 claims description 47
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 47
- 238000006243 chemical reaction Methods 0.000 claims description 41
- 239000000243 solution Substances 0.000 claims description 22
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000007853 buffer solution Substances 0.000 claims description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 9
- 241001109669 Human coronavirus HKU1 Species 0.000 claims description 9
- 241000711467 Human coronavirus 229E Species 0.000 claims description 8
- 241001428935 Human coronavirus OC43 Species 0.000 claims description 8
- 241000482741 Human coronavirus NL63 Species 0.000 claims description 7
- 239000013642 negative control Substances 0.000 claims description 7
- 102100034343 Integrase Human genes 0.000 claims description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 5
- 108091028733 RNTP Proteins 0.000 claims description 4
- 238000010791 quenching Methods 0.000 claims description 4
- 230000000171 quenching effect Effects 0.000 claims description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 3
- 101710203526 Integrase Proteins 0.000 claims description 3
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical class [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 claims description 3
- 102000009609 Pyrophosphatases Human genes 0.000 claims description 3
- 108010009413 Pyrophosphatases Proteins 0.000 claims description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- 239000003161 ribonuclease inhibitor Substances 0.000 claims description 3
- 125000006853 reporter group Chemical group 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 19
- 238000000034 method Methods 0.000 abstract description 19
- 238000012360 testing method Methods 0.000 abstract description 14
- 238000012544 monitoring process Methods 0.000 abstract description 7
- 208000001528 Coronaviridae Infections Diseases 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 230000004907 flux Effects 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 28
- 102000053602 DNA Human genes 0.000 description 26
- 238000001179 sorption measurement Methods 0.000 description 26
- 239000013612 plasmid Substances 0.000 description 15
- 238000003757 reverse transcription PCR Methods 0.000 description 12
- 241000700605 Viruses Species 0.000 description 10
- 150000007523 nucleic acids Chemical class 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000005119 centrifugation Methods 0.000 description 9
- 102000039446 nucleic acids Human genes 0.000 description 9
- 108020004707 nucleic acids Proteins 0.000 description 9
- 108020004682 Single-Stranded DNA Proteins 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000003612 virological effect Effects 0.000 description 5
- 229920000936 Agarose Polymers 0.000 description 4
- 230000009514 concussion Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000012925 reference material Substances 0.000 description 4
- 108700039887 Essential Genes Proteins 0.000 description 3
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
- 239000013614 RNA sample Substances 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 241001493065 dsRNA viruses Species 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
- 238000011901 isothermal amplification Methods 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 101150072531 10 gene Proteins 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 238000012952 Resampling Methods 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of kit and its application for being used to detect coronavirus.Contain the primer pair group for being used for detecting coronavirus in kit provided by the present invention, be made up of 2 primer pairs, its sequence is sequence 14 in sequence table.Kit provided by the invention supports high flux, coronavirus infection can quickly and accurately be detected, for clinic, the testing result that 2 kinds of coronavirus indexs can be obtained in 1 hour is not only faster than the real time fluorescence quantifying PCR method more generally used at present, and also significant for the treatment of quick auxiliary direction and medication.Meanwhile the detection of multi objective can be used for regional epidemiological survey and epidemic situation monitoring, to study popularity of the coronavirus infection in China.
Description
Technical field
The invention belongs to nucleic acid amplification technologies field, is related to a kind of kit and its application for being used to detect coronavirus.
Background technology
Coronavirus belongs to coronaviridae (Coronaviridae) coronavirus genus in genealogical classification
(Coronavirus).The virus of coronavirus genus be have outer embrane (envelope) normal chain single-stranded RNA virus, diameter about 80-
120nm, its inhereditary material are maximum in all RNA virus, only infect people, mouse, pig, cat, dog, birds vertebrate.It is coronal
One mutation of virus is to cause the pathogen of SARS, belongs to RNA virus.Coronavirus is nineteen thirty-seven at first from chicken body
On separate, the diameter 60-200nm of virion, average diameter 100nm are spherical in shape or oval, have polymorphy.
Virus has coating, spinous process be present on coating, and whole virus has obvious difference as corona, the spinous process of different coronavirus.
Coronavirus infection can see the inclusion body of tubulose sometimes into the cell.
Coronavirus infection is distributed in the multiple areas in the whole world, China and Britain, the U.S., Germany, Japan, Russia,
The states such as Finland, India have found this viral presence.Infection occurs mainly in winter and early spring caused by the virus.In the U.S.
Family of Michigan State proves in checking, coronavirus can infect each age group, and 0-4 year accounts for 29.2%, 40 years old with
On account for 22%, in 15-19 year age group incidence of disease highest.The popularity of this and other upper respiratory track viruses is not quite similar.Mesh
Preceding known, coronaviridae only infects vertebrate, relevant with many diseases of humans and animals.From 1980 was held in Germany
Since one international coronavirus discussion, the extensive attention of medical science, veterinary science and molecular biologist has been increasingly subject to.This kind of disease
Poison has the preferendum of intestines and stomach, respiratory tract and nervous system.
Rapid＆Early diagnosis coronavirus infection can guiding clinical treatment be in time reasonable selection antiviral antibacterial medicine
Thing offer foundation is simultaneously significant in terms of abuse of antibiotics is prevented.
The method of detection coronavirus is more at present, but all Shortcomings, such as Electronic Speculum detection method complex and expensive, virus point
Extremely length is taken from culture and false negative is more, and clinical meaning, ELISA detection have generally been lost after cultivation results are taken
Be special viral antibody but be once only capable of detecting a kind of virus.And the detection of nucleic acids based on nucleic acid amplification, because speed is fast
(can complete to detect in usual 3 hours), high sensitivity, specificity are good, and goldstandard is increasingly becoming in field of virus detection.
The amplification technique (Nucleic Acid Sequence Based Amplification) of nucleotide sequence is relied on, i.e.,
NASBA amplification techniques, it is to be mediated by pair of primers, be specific in vitro and continuous homogeneous to single stranded RNA progress constant temperature expansion
The process of increasing.Under 41 DEG C of constant temperatures, in terms of reaction speed, template ribonucleic acid can be expanded about 10 by NASBA amplifications 1h9~1012
Times, and common PCR reactions need 2~3h.In terms of detection sensitivity, NASBA, which can be detected, is less than 10gene in solution
Copies/ μ l trace target, and PCR test limit is in 100gene copies/ μ l or so.Therefore, NASBA technologies are either
Amplification efficiency or detection sensitivity are all higher than RT-PCR technology.And because NASBA reaction only needs one 41 DEG C of perseverance
Warm condition, water-bath can meet that reaction requires, it is not necessary to the temperature control device that the Standard PCR such as complicated heating and cooling is relied on, because
The instrument cost of this NASBA technology is very cheap.Combined with corresponding detection technique, NASBA also has easy to operate, specific
Many advantages, such as strong.
The content of the invention
First purpose of the present invention is to provide a kind of primer pair group for being used to detect coronavirus.
The primer pair group provided by the present invention for being used to detect coronavirus, is made up of following 2 primer pairs：
The primer pair 1 being made up of two single strand dnas shown in sequence in sequence table 1 and sequence 2；By sequence in sequence table
The primer pair 2 of two single strand dnas composition shown in row 3 and sequence 4.
Wherein, the primer pair 1 (Corn_OC) is used to expand HCoV-HKU1/OC43；(the Corn_ of primer pair 2
NL) it is used to expand HCoV-229E/NL63.
Second object of the present invention is to provide a kind of complete single stranded DNA for being used to detect coronavirus.
The complete single stranded DNA provided by the present invention for being used to detect coronavirus, by probe groups and the primer pair group group
Into；The probe groups are made up of following 2 ssDNA probes：SsDNA probe 1 in sequence table shown in sequence 5；Sequence table
SsDNA probe 2 shown in middle sequence 6.
Wherein, the ssDNA probe 1 (Corn_OC_MB) is used for the amplification for monitoring the primer pair 1 in real time；Institute
State the amplification that ssDNA probe 2 (Corn_NL_MB) is used to monitor the primer pair 2 in real time.
5 ' the ends mark of every ssDNA probe in the probe groups has FAM, and 3 ' ends mark
There is fluorescent quenching group TAMRA.
In the complete single stranded DNA provided by the present invention, each primer pair and its corresponding ssDNA probe can be single
Solely it is packaged in a packaging.As the primer pair 1 and the ssDNA probe 1 are packaged in first packaging；The primer
2 and the ssDNA probe 2 are packaged in second packaging.
Third object of the present invention is to provide a kind of kit for being used to detect coronavirus.
The kit provided by the present invention for being used to detect coronavirus, contains the primer pair group or described complete single-stranded
DNA。
The kit can also contain internal reference primer pair and internal reference probe.The internal reference primer pair is for expanding
House-keeping gene GAPDH mRNA primer pair GAPD_IC in human genome, as two shown in sequence in sequence table 7 and sequence 8
Single strand dna forms.The internal reference probe (GAPD_IC_MB) is the ssDNA probe shown in sequence 9 in sequence table, is used
In the amplification for monitoring the internal reference primer pair (GAPD_IC) in real time.
5 ' ends of the internal reference probe are marked with fluorescent reporter group FAM, and 3 ' ends are marked with fluorescent quenching group
TAMRA。
Constant-temperature amplification buffer solution and constant-temperature amplification enzyme solutions can also be contained in the kit.
The solvent of the constant-temperature amplification buffer solution is water, and solute and concentration are as follows：200mM pH 8.0 Tris-HCL,
50mM DTT, 10mM dNTP, 10mM rNTP, 80mM MgCl2, 450mM KCl, 15% volumn concentration DMSO, 1M sorb
Alcohol, 20mM tetramethyl ammonium chlorides.
The solvent of the constant-temperature amplification enzyme solutions is water, and solute and concentration are as follows：AMV reverse transcriptase 1U/ μ l, T7RNA gather
Synthase 5U/ μ l, ribonuclease H 0.5U/ μ l, pyrophosphatase 0.5U/ μ l, RNase inhibitor 5U/ μ l, BSA0.5 μ g/ μ l.
Dish-style chip can also be contained in the kit, such as 24 reaction chamber dish-style chips.
In the present invention, the 24 reaction chamber dish-style chip is " the brilliant core of Capitalbio Corporation Co., Ltd.'s production
The supporting dish-style chip of RTisochipTM-A constant-temperature amplification micro-fluidic chips nucleic acids instrument ", its model 1 × 24.
The 1# of the dish-style chip deposits dry following (1)-(4) to 4# reaction chambers respectively：
(1) primer pair 1 and the ssDNA probe 1；(2) primer pair 2 and the ssDNA probe 2；(3)
The internal reference primer pair and the internal reference probe；(4) negative controls.
The negative controls concretely water without RNase (Rnase-free water).
Wherein, the method for primer and probe being embedded into dish-style chip is：By primer, the spy corresponding with the primer
Pin, agarose mixing, are configured to mixed solution, make the primer, the probe and the agarose in the mixed solution
Final concentration be respectively 0.2 μM, 50nM, 0.1% (weight/mass percentage composition)；Mixed solution described in 1 μ l is taken to click and enter corresponding dish-style
Chip reaction chamber, after being dried in clean super-clean bench, tabletting encapsulation, punching press is made after vacuumizing.
The non-diagnostic mesh of the primer pair group or complete single stranded DNA or kit in detecting or aiding in detection coronavirus
Application fall within protection scope of the present invention.
In the application, by constant-temperature amplification enzyme solutions described in constant-temperature amplification buffer solution described in 15 μ l and 10 μ l, with 25 μ l
It is injected into after the mixing of sample to be tested solution in the dish-style chip, isothermal reaction 1h at 41 DEG C.
In the application, sample to be tested can be used as using Nasopharyngeal swabs；Accordingly, the sample to be tested solution can be from nose
The RNA extracted in throat swab.
In the present invention, the coronavirus is concretely at least one of following：HCoV-HKU1/OC43 and hat
Shape virus 229E/NL63.
Kit provided by the invention supports high flux, can quickly and accurately detect coronavirus infection, for clinical
Speech, can be obtained in 1 hour 2 kinds of coronavirus indexs testing result be not only faster than it is current more generally use it is real-time glimmering
Fluorescent Quantitative PCR method, and it is also significant for the treatment of quick auxiliary direction and medication.Meanwhile the detection of multi objective
Regional epidemiological survey and epidemic situation monitoring are can be used for, to study popular feelings of the coronavirus poison infection in China
Condition.
Brief description of the drawings
Fig. 1 is dish-style chip and primer sample application cavity schematic diagram.
Fig. 2 is 2 kinds of coronavirus reference material dish-style chip testing result figures.Wherein, A be containing HCoV-HKU1/
Testing results of the recombinant plasmid pUC19-Corn_OC of OC43 target genes in 1# reaction chambers；B be containing HCoV-229E/
Testing results of the recombinant plasmid pUC19-Corn_NL of NL63 target genes in 2# reaction chambers.In A and B, E1 represents that template is
101Copy/μ l, by that analogy, E5 represent that template is 105Copy/μ l；NC represents negative control.
Embodiment
Experimental method used in following embodiments is conventional method unless otherwise specified.
Material used, reagent etc., unless otherwise specified, are commercially obtained in following embodiments.
The preparation and its use of embodiment 1, kit for detecting coronavirus
First, for the preparation for the kit for detecting coronavirus
Kit forms provided by the present invention for detecting coronavirus are as follows：
1st, constant-temperature amplification buffer solution
The solvent of constant-temperature amplification buffer solution is water, and solute and concentration are as follows：200mM Tris-HCL (pH 8.0), 50mM
DTT, 10mM dNTP, 10mM rNTP, 80mM MgCl2, 450mM KCl, 15% volumn concentration DMSO, 1M sorbierite,
20mM tetramethyl ammonium chlorides.
2nd, constant-temperature amplification enzyme solutions
The solvent of constant-temperature amplification enzyme solutions is water, and solute and concentration are as follows：AMV reverse transcriptase 1U/ μ l, t7 rna polymerase
5U/ μ l, ribonuclease H 0.5U/ μ l, pyrophosphatase 0.5U/ μ l, RNase inhibitor 5U/ μ l, BSA0.5 μ g/ μ l.
3rd, 24 reaction chamber dish-style chips of primer pair and ssDNA probe are mounted with
The 24 reaction chamber dish-style chip is " the brilliant core RTisochipTM-A perseverances of Capitalbio Corporation Co., Ltd.'s production
The supporting dish-style chip of temperature amplification micro-fluidic chip nucleic acids instrument ", its model 1 × 24, schematic diagram is as shown in Figure 1.
The 1# of the 24 reaction chamber dish-style chip deposits dry following (1)-(4) to 4# reaction chambers respectively：
(1) primer pair 1 and ssDNA probe 1；(2) primer pair 2 and ssDNA probe 2；(3) internal reference primer pair and interior
Control probe；(4) negative controls.The negative controls are specially the water (Rnase-free water) without RNase.
Wherein, the primer pair 1 (Corn_OC) is used to expand HCoV-HKU1/OC43, by the He of sequence in sequence table 1
Two single strand dnas composition shown in sequence 2；The primer pair 2 (Corn_NL) is used to expand HCoV-229E/NL63,
It is made up of two single strand dnas shown in sequence in sequence table 3 and sequence 4.The internal reference primer pair (GAPD_IC) is used for
House-keeping gene GAPDH mRNA in human genome are expanded, as two single strand dnas shown in sequence in sequence table 7 and sequence 8
Composition.
The ssDNA probe 1 (Corn_OC_MB) is used for the amplification for monitoring the primer pair 1 in real time, its nucleosides
Acid sequence is sequence 5 in sequence table；The ssDNA probe 2 (Corn_NL_MB) is used for the expansion for monitoring the primer pair 2 in real time
Increase result, its nucleotides sequence is classified as sequence 6 in sequence table.The internal reference probe (GAPD_IC_MB) is used for described in monitoring in real time
The amplification of internal reference primer pair (GAPD_IC), its nucleotides sequence are classified as sequence 9 in sequence table.Every the single stranded DNA is visited
5 ' the ends mark of pin and the internal reference probe (GAPD_IC_MB) has FAM, and 3 ' ends mark has
Optical quenching group TAMRA.
Wherein, the method for primer and probe being embedded into dish-style chip is：By primer, the spy corresponding with the primer
Pin, agarose mixing, are configured to mixed solution, make the primer, the probe and the agarose in the mixed solution
Final concentration be respectively 0.2 μM, 50nM, 0.1% (weight/mass percentage composition)；Mixed solution described in 1 μ l is taken to click and enter corresponding dish-style
Chip reaction chamber, after being dried in clean super-clean bench, tabletting encapsulation, punching press is made after vacuumizing.
2nd, for the application method for the kit for detecting coronavirus
1st, reaction system is prepared
15 μ l constant-temperature amplifications buffer solutions (see step 1 1), 10 μ l constant-temperature amplifications enzyme solutions (see step 1 2), 25 μ l are taken to treat
This liquid of test sample is mixed into 50 μ l reaction solutions, after vortex concussion uniformly injection be mounted with primer pair and the 24 of ssDNA probe anti-
Chamber dish-style chip (see step 1 3) is answered, seals Quick spin 30s after membrana oralis.
2nd, isothermal amplification reactions and detection
Dish-style chip is placed in rich Isochip-RT constant-temperature amplifications instrument difficult to understand, sets 41 DEG C to react 1 hour, and complete simultaneously
Real-time fluorescence scans.
3rd, result judges
After reaction terminates, the sample to be tested liquid is determined according to the amplification curve of sample in each reaction chamber as follows
In whether contain corresponding coronavirus genome：If the testing sample produces S type amplification curves, the sample to be tested liquid
In contain corresponding coronavirus genome；Conversely, the genome of corresponding coronavirus is not contained in the sample to be tested liquid then.
Embodiment 2, the analysis of the sensitivity and specificity of kit for detecting coronavirus
First, the preparation of reference material RNA nucleic acid
1st, structure includes the plasmid of coronavirus target gene
(1) plasmid of HCoV-HKU1/OC43 target genes is contained
By 20438~21549 sections (HCoV-HKU1/OC43 targets of HCoV-HKU1/OC43 target gene sequences
Mark the Genbank Sequence ID of gene order:Gb | KF686344.1 |, Update Date：2014-9-26) it is inserted into
Between the multiple cloning sites EcoR V of pUC19 carriers (day is with biochemical corp's product), recombinant plasmid pUC19-Corn_OC is obtained.
(2) plasmid of HCoV-229E/NL63 target genes is contained
By 15715~17379 sections (HCoV-229E/NL63 targets of HCoV-229E/NL63 target gene sequences
Mark the Genbank Sequence ID of gene order:Gb | JQ765566.1 |, Update Date：2014-9-26) it is inserted into
Between the multiple cloning sites EcoR V of pUC19 carriers (day is with biochemical corp's product), recombinant plasmid pUC19-Corn_NL is obtained.
2nd, the preparation of reference material RNA nucleic acid
For trying recombinant plasmid：2 kinds of recombinant plasmids for containing corresponding coronavirus target gene that step 1 is built.
(1) digestion：First 37 DEG C of digestion 2h of EcoRI restriction endonucleases are used by each for examination recombinant plasmid.
(2) transcribe：It polymerize by 5 μ l 5 × Transcription Optimized Buffer (Promega), 2U T7RNA
Enzyme, 10mM DTT (Promega), 10U recombinant RNAs enzyme inhibitor (Promega), 2mM rNTP, the μ l of digestion products 5 prepare overall
Product is 50 μ l reaction system, 37 DEG C of transcription 4h after shaking uniformly.
(3) digest：System after the completion of transcription is added to 1 μ l DNA digestive ferments (rDnaseI, 5U/ μ l), concussion centrifuges,
37 DEG C of incubation 20min.
(4) purify：Using the RNA purification kits products of Macherey-Nagel companies, (its catalog number is
740948) transcription product RNA is purified as follows：A) RA1-C is prepared2H5OH mixed liquors：With RA1:C2H5OH=1:1 (volume
Than) ratio prepare., it is necessary to add 600 μ l RA1-C in every 100 μ l transcription product2H5OH mixed liquors, i.e. 300 μ l RA1+
300μl C2H5OH solution, need to calculate the volume for matching somebody with somebody mixed liquor according to the pipe number of transcription product herein.If product is insufficient
100 μ l, then the amount of product is mended to 100 μ l with water and (50 μ l Tiangeng Rnase-free H are added in every pipe product2O)。
B) the ready RA1-C by before2H5OH mixed liquors are assigned in 1.5ml centrifuge tubes, two pipes, often the μ l of pipe 600, and 100 μ l products are turned
Enter into corresponding centrifuge tube, totally 700 μ l, fully shaking centrifuge in pipe.C) prepare two adsorption columns, and carry out corresponding mark
Note, 700 μ l product mixtures are transferred in adsorption column (adsorption column maximum capacity is 700 μ l), 1.2 ten thousand rpm centrifugation 2min, are fallen
Fall down a layer solution.D) 700 μ l RA3 is added in adsorption column, 1min is placed, it is sufficiently dispersed in the bottom of adsorption column
Portion, 1.2 ten thousand rpm centrifugation 2min, outwells lower floor's solution.E) 350 μ l RA3 is added in adsorption column, places 2min, 1.2 ten thousand rpm
2min is centrifuged, outwells lower floor's solution.F) 300 μ l RA3 is added in adsorption column, 2min is placed, 1.2 ten thousand rpm centrifugation 2min, falls
Fall down a layer solution.G) after the lid 3min for opening adsorption column, 1.2 ten thousand rpm skies outwell lower floor's solution, repeat this step from 2min
Once.H) it is empty from end after, adsorption column is transferred in corresponding centrifuge tube, opens adsorption column lid and place 15min, make
Ethanol volatilization is complete, and 60 μ l Rnase-H are added in adsorption column2O (carries) elution in kit, place 2min, and 1.2 ten thousand
Rpm centrifuges 2min.I) centrifugation gained template is sucked back in adsorption column, places 2min, 1.2 ten thousand rpm centrifugation 2min, repeat this step
Twice.J) adsorption column is lost, the template in centrifuge tube is taken out into 2 μ l, determines its concentration with Nano drop, and record its concentration
And its 260/280,260/230 ratio.
2nd, for the sensitivity and specificity analysis for the kit for detecting coronavirus
1st, prepared by the reference material template of various concentrations
It is fixed that each RNA templates (the 2 kinds of recombinant plasmids built in corresponding step 1 1) of above-mentioned steps one after purification are calculated
Measure to 1010Copy/μ l, and gradient dilution, obtain 105Copy/μ l, 104Copy/μ l, 103Copy/μ l, 102Copy/μ l, 10 are copied
The template dilution of the various concentrations such as shellfish/μ l.
2nd, reaction system is prepared
15 μ l constant-temperature amplifications buffer solutions are taken (see the step 1) of embodiment 1,10 μ l constant-temperature amplifications enzyme solutions (see the step of embodiment 1
2), the template dilution of 25 μ l concentration is mixed into 50 μ l reaction solutions, after vortex concussion uniformly injection be mounted with primer pair and
24 reaction chamber dish-style chips of ssDNA probe (see the step 3) of embodiment 1, seal Quick spin 30s after membrana oralis.
3rd, isothermal amplification reactions and detection
Dish-style chip is placed in rich Isochip-RT constant-temperature amplifications instrument difficult to understand, sets 41 DEG C to react 1 hour, and complete simultaneously
Real-time fluorescence scans.And result is judged according to the method for the step 23 of embodiment 1.
3rd, result
As a result it is as shown in Figure 2：
(1) for recombinant plasmid pUC19-Corn_OC RNA sample, the 1# reaction chambers of 24 reaction chamber dish-style chips
To 105Copy/μ l, 104Copy/μ l, 103Copy/μ l, 102The testing result of copy/μ l, 10 copies/μ l templates has substantially
S type amplification curves, be shown as positive；And 2# reaction chambers are shown as negative without amplification curve.
(2) for recombinant plasmid pUC19-Corn_NL RNA sample, the 2# reaction chambers of 24 reaction chamber dish-style chips
To 105Copy/μ l, 104Copy/μ l, 103Copy/μ l, 102The testing result of copy/μ l, 10 copies/μ l templates has substantially
S type amplification curves, be shown as positive；And 1# reaction chambers are shown as negative without amplification curve.
In addition, for the RNA sample of 2 kinds of all recombinant plasmids, the 3# reaction chambers of 24 reaction chamber dish-style chips are (interior
Control) and 4# reaction chambers (negative control) without amplification curve.3# reaction chambers (internal reference) why without amplification curve be because
Sample to be tested is the RNA nucleic acid of 2 kinds of recombinant plasmids, does not contain the RNA of house-keeping gene GAPDH in human genome.
It these results suggest that the kit has higher amplification sensitivity and specific amplification.
The detection of embodiment 3, actual clinical sample
First, clinical sample type
The present embodiment use clinical sample from Shenzhen San Yuan in collection Nasopharyngeal swabs sample (in line with this picker from
The principle of hope), adopt swab and deposit in 3mL physiological saline, totally 560.
2nd, in clinical sample viral nucleic acid extraction
Clinical sample viral nucleic acid extraction kit used is QIAamp Viral RNA Mini Kit (Qiagen),
Extracted as follows：
(1) take and the μ l of physiological saline 140 of clinical sample swab are deposited in step 1 in 1.5ml centrifuge tubes；
(2) Buffer AVL (the i.e. 5.6 μ l Carrier RNA mixing that 560 μ l contain Carrier RNA mixed liquors is added
The μ l Buffer of liquid+560 AVL are in centrifuge tube, slight whirlpool 15s；
(3) after the completion of brief centrifugation, (15-25 DEG C) placement 10-20min of room temperature, to ensure Buffer AVL in centrifuge tube
In have abundance time cracked；
(4) 560 μ l ethanol (96-100%, volumn concentration) are added in centrifuge tube, whirlpool mixes 15s, centrifugation；
(5) 630 μ l sample solutions are taken in adsorption column, 2min is placed, it is fully contacted with adsorption column, 8000rpm, from
Heart 1min, change clean collecting pipe；
(6) if sample solution is more than 630 μ l, repeatedly previous step；
(7) 500 μ l AW1 washing lotions are added in adsorption column, 2min is placed, it is fully contacted with adsorption column, 8000rpm
1min is centrifuged, changes clean collecting pipe；
(8) 500 μ l AW2 washing lotions are added in adsorption column, 2min is placed, it is fully contacted with adsorption column,
12000rpm centrifuges 3min, changes clean collecting pipe；
(9) 300 μ l AW2 washing lotions are added in adsorption column, 2min is placed, it is fully contacted with adsorption column,
12000rpm centrifuges 3min, changes clean collecting pipe；
(10) adsorption column lid is opened and places 2min, make that its inside and outside pressure is consistent, and 8000rpm skies are from 1min.It is empty from knot
Shu Yihou, repeat this step once.
(11) it is empty from end after, adsorption column is transferred in 1.5ml centrifuge tubes, open adsorption column lid, place 20-30min,
Make ethanol volatilization complete；
(12) 50 μ l Buffer AVE elution nucleic acid, 8000rpm centrifugation 1min, after centrifugation is completed, by under elution are added
Nucleic acid suck back adsorption column, lose adsorption column after centrifuging 1min.
3rd, the detection of actual clinical sample
1st, reaction system is prepared
15 μ l constant-temperature amplifications buffer solutions (see the step 11 of embodiment 1), 10 μ l constant-temperature amplifications enzyme solutions are taken (see the step of embodiment 1
Rapid 1 2), the clinical sample solution that 25 μ l step 2 are extracted to obtain is mixed into 50 μ l reaction solutions, is injected after vortex concussion uniformly
It is mounted with the 24 reaction chamber dish-style chips (see the step 13 of embodiment 1) of primer pair and ssDNA probe, seals rapid after membrana oralis
Centrifuge 30s.
2nd, isothermal amplification reactions and detection
Dish-style chip is placed in rich Isochip-RT constant-temperature amplifications instrument difficult to understand, sets 41 DEG C to react 1 hour, and complete simultaneously
Real-time fluorescence scans.And result is judged according to the method for the step 23 of embodiment 1.
Experiment sets reliability demonstration of the conventional RT-PCR method for kit testing result of the present invention simultaneously.For examining
It is as shown in table 1 to survey each viral specific RT-PCR primer sequence.
Table 1 is used for the specific RT-PCR primer sequence for detecting 2 kinds of coronavirus
| Index name | RT-PCR sense primers (5 ' -3 ') | RT-PCR anti-sense primers (5 ' -3 ') |
| HCoV-HKU1/OC43 | AGGCTGTATGATGAATGTTGCTAAG | CCTGCACCTAAATGYAAAACWCGCATAT |
| HCoV-229E/NL63 | CAATACAGGGTCCTCCTGGTAGTGG | CACTACCAGGAGGACCCTGTATTGT |
4th, result
The testing result of kit of the present invention is shown, for each coronavirus, is detected using RT-PCR method positive
Sample example using kit of the present invention detection show positive findings.In addition, for a few sample example, using RT-PCR
Method detection is negative, but uses kit testing result of the present invention as the positive.By carrying out later stage resampling to these sample examples
RT-PCR is detected, it is found that it is positive these sample examples are detected as corresponding coronavirus really.Indicated above, kit of the present invention is to phase
The recall rate of coronavirus is answered to be higher than RT-PCR methods, and its testing result is accurately and reliably.Kit and RT-PCR method inspection of the present invention
The statistical result of coronavirus clinical sample is surveyed referring to table 2.
The statistical result of 2 kit of the present invention of table and RT-PCR methods detection coronavirus clinical sample
Claims (3)
1. the kit for detecting coronavirus, contains probe groups and primer pair group；
The primer pair group, it is made up of following 2 primer pairs：
Sequence 1 and the primer pair 1 shown in sequence 2 in sequence table；
Sequence 3 and the primer pair 2 shown in sequence 4 in sequence table；
The probe groups are made up of following 2 probes：Probe 1 in sequence table shown in sequence 5；In sequence table shown in sequence 6
Probe 2；
5 ' the ends mark of each probe in the probe groups has FAM, and 3 ' ends mark has
Group TAMRA；
The kit also contains internal reference primer pair and internal reference probe；Sequence 7 in the internal reference primer pair such as sequence table
Shown in sequence 8；The internal reference probe is the probe shown in sequence 9 in sequence table；5 ' end marks of the internal reference probe
There is fluorescent reporter group FAM, 3 ' ends are marked with fluorescent quenching group TAMRA；
Also contain dish-style chip in the kit；
The 1# of the dish-style chip deposits dry as follows respectively to 4# reaction chambers（1）-（4）：
（1）The primer pair 1 and the probe 1；
（2）The primer pair 2 and the probe 2；
（3）The internal reference primer pair and described internal reference probe；
（4）Negative controls；
The dish-style chip is 24 reaction chamber dish-style chips.
2. kit according to claim 1, it is characterised in that：In the kit also containing constant-temperature amplification buffer solution and
Constant-temperature amplification enzyme solutions；
The solvent of the constant-temperature amplification buffer solution is water, and solute and concentration are as follows：200mM pH 8.0 Tris-HCL, 50mM
DTT, 10mM dNTP, 10mM rNTP, 80mM MgCl2, 450mM KCl, 15% volumn concentration DMSO, 1M sorbierite,
20mM tetramethyl ammonium chlorides；
The solvent of the constant-temperature amplification enzyme solutions is water, and solute and concentration are as follows：AMV reverse transcriptase 1U/ μ l, T7 RNA polymerize
Enzyme 5U/ μ l, ribonuclease H 0.5U/ μ l, the μ g/ μ l of pyrophosphatase 0.5U/ μ l, RNase inhibitor 5U/ μ l, BSA 0.5.
3. kit according to claim 1 or 2, it is characterised in that：The coronavirus virus in following at least
It is a kind of：HCoV-HKU1/OC43 and HCoV-229E/NL63.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510479272.9A CN105112559B (en) | 2015-08-03 | 2015-08-03 | A kind of kit and its application for being used to detect coronavirus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510479272.9A CN105112559B (en) | 2015-08-03 | 2015-08-03 | A kind of kit and its application for being used to detect coronavirus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105112559A CN105112559A (en) | 2015-12-02 |
| CN105112559B true CN105112559B (en) | 2017-12-08 |
Family
ID=54660661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510479272.9A Active CN105112559B (en) | 2015-08-03 | 2015-08-03 | A kind of kit and its application for being used to detect coronavirus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105112559B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110724764A (en) * | 2019-10-22 | 2020-01-24 | 中国医学科学院病原生物学研究所 | Fluorescent quantitative PCR detection method for human coronavirus and respiratory syncytial virus and application thereof |
| CN212142656U (en) * | 2020-02-21 | 2020-12-15 | 南京岚煜生物科技有限公司 | Closed micro-fluidic chip |
| CN111154919A (en) * | 2020-03-04 | 2020-05-15 | 南京大学 | Novel coronavirus kit and method for detecting novel coronavirus nucleic acid by using single closed tube one-step method |
| CN111041129B (en) * | 2020-03-13 | 2020-06-05 | 博奥生物集团有限公司 | Primer-probe combination for detecting 6 respiratory viruses, kit and application |
| CN111257555A (en) * | 2020-04-03 | 2020-06-09 | 安徽省疾病预防控制中心（省健康教育所） | Rapid detection method and test strip for lateral chromatography colloidal gold of new coronavirus nucleic acid recombinase mediated isothermal amplification |
| CN111218502B (en) * | 2020-04-23 | 2020-07-21 | 圣湘生物科技股份有限公司 | Composition for improving qPCR detection performance, reaction solution, application and method |
| CN111795986A (en) * | 2020-05-20 | 2020-10-20 | 万秋花 | Virus clinical examination detection platform applying shape search |
| CN111808989A (en) * | 2020-06-18 | 2020-10-23 | 重庆浦洛通基因医学研究院有限公司 | Coronavirus/influenza virus/rhinovirus nucleic acid combined detection kit and use method thereof |
| CN111893215A (en) * | 2020-07-15 | 2020-11-06 | 四川大学华西医院 | Multiplex-time PCR kit for detecting coronavirus, method and application |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004111274A1 (en) * | 2003-06-10 | 2004-12-23 | bioMérieux B.V. | Nucleic acid sequences that can be used as primers and probes in the amplification and detection of sars coronavirus |
| CN101603096A (en) * | 2009-05-04 | 2009-12-16 | 北京海康基因芯片开发有限公司 | A kind of method and test kit that detects infectious disease pathogens |
| CN103831140A (en) * | 2014-03-07 | 2014-06-04 | 博奥生物集团有限公司 | Micro-fluidic chip for multi-index detection |
| CN105018648A (en) * | 2015-08-03 | 2015-11-04 | 博奥生物集团有限公司 | Kit for detecting respiratory viruses and application thereof |
-
2015
- 2015-08-03 CN CN201510479272.9A patent/CN105112559B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004111274A1 (en) * | 2003-06-10 | 2004-12-23 | bioMérieux B.V. | Nucleic acid sequences that can be used as primers and probes in the amplification and detection of sars coronavirus |
| CN101603096A (en) * | 2009-05-04 | 2009-12-16 | 北京海康基因芯片开发有限公司 | A kind of method and test kit that detects infectious disease pathogens |
| CN103831140A (en) * | 2014-03-07 | 2014-06-04 | 博奥生物集团有限公司 | Micro-fluidic chip for multi-index detection |
| CN105018648A (en) * | 2015-08-03 | 2015-11-04 | 博奥生物集团有限公司 | Kit for detecting respiratory viruses and application thereof |
Non-Patent Citations (2)
| Title |
|---|
| Enhanced Identification of Viral and Atypical Bacterial Pathogens in Lower Respiratory Tract Samples With Nucleic Acid Amplification Tests;Bonita E. Lee,et al;《Journal of Medical Virology》;20061231;第78卷;702-710 * |
| Real-Time NASBA Detection of SARS-Associated Coronavirus and Comparison With Real-Time Reverse Transcription-PCR;Maria Cristina Keightley,et al;《Journal of Medical Virology》;20051231;第77卷;602–608 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105112559A (en) | 2015-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105112559B (en) | A kind of kit and its application for being used to detect coronavirus | |
| CN105018648B (en) | A kind of kit and its application for being used to detect Respirovirus | |
| CN111020064B (en) | Novel coronavirus ORF1ab gene nucleic acid detection kit | |
| CN105039597B (en) | A kind of kit and its application for being used to detect influenza virus | |
| CN107513584B (en) | A kind of five heavy fluorescence quantitative kits detecting enterovirus | |
| CN105400907A (en) | Kit for nucleic acid combined detection of influenza virus A, influenza virus B and respiratory syncytial virus | |
| CN105018488B (en) | Kit and its application for detecting Respirovirus | |
| CN107058623A (en) | A kind of High sensitivity and special blood HBV pgRNA fluorescence quantitative PCR detections systems and detection method | |
| CN101942525B (en) | One-tube method with multiplex detection for human Influenza A and B and new Influenza A H1N1 virus and kit | |
| CN111534637B (en) | Universal primer, probe and kit for enterovirus nucleic acid detection | |
| CN103045754B (en) | One-step process real-time fluorescent quantitative RT-PCR (Reverse Transcription-Polymerase Chain Reaction) method and kit for detecting Z/S subtype ebola viruses | |
| CN101948931A (en) | Single-tube multiplex fluorescence PCR (Polymerase Chain Reaction) detection method and kit for 1,2,3-type parainfluenza viruses | |
| CN106978511A (en) | A kind of method for detecting feline herpetovirus | |
| CN105112407B (en) | A kind of kit and its application for being used to detect enterovirus | |
| CN103966356A (en) | Human immunodeficiency virus type 1 one-step fluorescence quantitative RT-PCR detection kit | |
| CN105907890A (en) | Primers, probe and method for rapidly distinguishing HP-PRRS (High pathogenic porcine reproductive and respiratory syndrome) vaccine strain GDr180 from HP-PRRS wild strain | |
| CN106636454A (en) | Real-time fluorescence multi-RT-PCR (Reverse Transcription-Polymerase Chain Reaction) method for simultaneously detecting human coronaviruses 229E, OC43, NL63 and HKU1 | |
| CN107513583A (en) | Detect the absolute fluorescence quantification PCR primer and kit of the pestivirus of atypia pig | |
| CN107083446A (en) | Diarrhoea pathogenic bacteria multiple gene detection architecture and its kit and application | |
| CN108239676A (en) | A kind of parainfluenza virus one-step method fluorescence parting RT-PCR detection kit | |
| CN105154584B (en) | A kind of the HRM non-marked detecting probe method and its primer and probe of quick differentiation PRRSV classical strains and variation strain | |
| CN103276099A (en) | Primer and kit for fluorescent quatititive PCR (polymerase chain reaction) detection of helicobacter pylori | |
| CN108411014A (en) | Differentiate the primer and probe and detection method of A types and the dual real-time fluorescence quantitative PCR of Type B ox pasteurella multocida | |
| CN103146846A (en) | Single standard product-based four-color fluorogenic quantitative PCR (Polymerase Chain Reaction) method and kit | |
| CN105039596B (en) | A kind of kit and its application for being used to detect parainfluenza virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |